Lumvoa Injection
Product Images NDC 85166-001

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lumvoa (NDC 85166-001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Viridian Therapeutics, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Vel03 0002 01)

This text appears to be a table showing measurements of proptosis change from baseline for two different groups, one receiving placebo and the other Lumvoa. The measurements are taken at baseline, week 3, and week 6. The data shows the change in the value in millimeters.*

FDA Label Image

Figure (Vel03 0002 02)

FDA Label Image

Principal Display Panel (500 mg/10 mL Carton Label)

This is a description of a pharmaceutical product called LUMVOA, which is an injection to be stored refrigerated at 2°C to 8°C. The injection contains veligrotug-wze, histidine, L-histidine hydrochloride monohydrate, methionine, polysorbate 80, sucrose, and Water for Injection. It is a single-dose vial for intravenous use only, and any unused portion should be discarded. The product is manufactured by Viridian Therapeutics, Inc. located in Waltham, MA. It is advised not to freeze or shake the vial and to dilute prior to use as indicated in the prescribing information.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.